2005
DOI: 10.1182/blood-2004-12-4831
|View full text |Cite
|
Sign up to set email alerts
|

Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines

Abstract: IntroductionFas-FasL (Fas ligand) interaction has been long viewed as a means to achieve immune down-regulation by mediating apoptosis of activated T cells and other sensitive cells by providing immune privilege for organs such as eyes and testis, and by inhibiting immune response in the immune escape of tumors. [1][2][3][4] However, when FasL was transfected into various murine transplants, with the expectation that it would promote immune tolerance, it was found to cause neutrophil infiltration and to exacer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
44
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 54 publications
(47 citation statements)
references
References 41 publications
3
44
0
Order By: Relevance
“…Our previous studies showed that Fas signaling could promote lung cancer growth by recruiting myeloid-derived suppressor cells (MDSCs) 4 in vivo (20), and the bioactive Fas ligand (FasL) released by activated T cells in exosomes could promote melanoma and lung cancer cell metastasis through Fas signaling (21). Furthermore, Fas ligation promotes not only survival but also an increase in maturation of dendritic cells (DCs) and induces DCs to rapidly produce both CXC and CC chemokines, which results in enhanced chemoattraction of neutrophils and T cells in vivo or in vitro (22,23). In some instances cytokines and chemokines can recruit antitumor immune effector cells so as to control tumor progression (24,25); however, cytokines and chemokines in the tumor microenvironment usually recruit immunosuppressive cells to help tumor escape immunological attack and promote angiogenesis (20 -21, 26).…”
mentioning
confidence: 99%
“…Our previous studies showed that Fas signaling could promote lung cancer growth by recruiting myeloid-derived suppressor cells (MDSCs) 4 in vivo (20), and the bioactive Fas ligand (FasL) released by activated T cells in exosomes could promote melanoma and lung cancer cell metastasis through Fas signaling (21). Furthermore, Fas ligation promotes not only survival but also an increase in maturation of dendritic cells (DCs) and induces DCs to rapidly produce both CXC and CC chemokines, which results in enhanced chemoattraction of neutrophils and T cells in vivo or in vitro (22,23). In some instances cytokines and chemokines can recruit antitumor immune effector cells so as to control tumor progression (24,25); however, cytokines and chemokines in the tumor microenvironment usually recruit immunosuppressive cells to help tumor escape immunological attack and promote angiogenesis (20 -21, 26).…”
mentioning
confidence: 99%
“…This killing of DCs may also explain the profound immunosuppression observed after certain viral infections such as measles [19]. Conversely, perhaps Fas signaling has an additional effect on DCs, as indicated by induction of chemokine production by DCs stimulated with anti-Fas [20]. If this is so, autoimmunity induced by the DCs in these experiments may be caused by increased DC activity induced by the very signals which are normally dampened by their ability to also drive DC death.…”
Section: Life and Death Of Antigen Presenting Dendritic Cellsmentioning
confidence: 89%
“…Our previous studies have shown that chemokine gene transfer can enhance DC-mediated and T cell-dependent anti-tumor immunity and thus represents a potent anti-tumor immunotherapeutic approach. [35][36][37] Therefore, increased chemokine secretion by DAMP-stimulated DCs is expected to exert strong chemoattractant effects on DCs and T cells, resulting in improved protective immunity and an enhanced T-cell response.…”
Section: Discussionmentioning
confidence: 99%